On March 26 in Toronto, more than 200 leaders, innovators, investors, and partners from Canada’s genomics and life sciences ecosystem gathered for Connect‑Bio Expanded—an event dedicated to omics technologies and their strategic role in advancing innovation in health and life sciences.
This dynamic day was driven by a shared ambition: to foster collaboration, accelerate partnerships, and turn scientific innovation into tangible outcomes for industry.
A Collaboration‑Driven Genomics Event
Throughout the event, participants engaged in high‑level discussions covering key topics such as:
- Investment strategies
- Regulatory pathways
- Commercialization challenges
- Real‑world success stories from the ecosystem
The energy and engagement were palpable, especially during networking sessions, where conversations continued well beyond the official agenda.
High‑Impact Biopartnering Meetings
Thanks to the biopartnering platform, this event enabled targeted and high‑value interactions:
- Over 385 meeting requests
- More than 170 qualified connections
- Over 160 scheduled one‑to‑one meetings
- 2,600+ messages exchanged, reflecting a highly engaged and active ecosystem
Strong Industry Engagement
The event brought together a broad range of innovation stakeholders in life sciences, with a strong industry presence: biotechnology companies and contract research organizations (CROs) accounted for more than 50% of participants.
🎙️ 16 expert speakers and panelists took the stage to:
- share insights and best practices,
- highlight Canada’s available resources,
- and showcase funding and collaboration opportunities across the ecosystem.
An Event Made Possible by Committed Partners
Connect‑Bio Expanded was made possible thanks to the support and engagement of key ecosystem partners, whom we sincerely thank:
NGen Canada, BIOQuébec, BIOTECanada, Genome Canada, Génome Québec, Life Sciences Ontario, and McGill University.
We also extend our thanks to all speakers, panelists, exhibitors, and participants who contributed to making this event a true success.
We firmly believe that these moments of connection are essential to accelerating innovation, strengthening collaborations, and enhancing Canada’s competitiveness in genomics and life sciences.
